Day: January 22, 2024

Franklin Electric Increases Quarterly Dividend by 11% to $0.25 Per Share

Written by Customer Service on January 22, 2024. Posted in Dividend Reports And Estimates.

FORT WAYNE, Ind., Jan. 22, 2024 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) announced today that its Board of Directors declared a quarterly cash dividend of $0.25 per share payable February 15, 2024, to shareholders of record on February 1, 2024. This represents an 11 percent increase from the prior quarterly dividend. “This dividend increase will mark the 32nd consecutive year that Franklin Electric has increased its dividend, demonstrating its commitment to rewarding shareholders and confidence in the outlook of the business,” commented Gregg Sengstack, Franklin Electric’s Chairperson and Chief Executive Officer. About Franklin ElectricFranklin Electric is a global leader in the production and marketing of systems and components for the movement of water and energy. Recognized as a technical leader in its products...

Former National Security Advisor General Michael Flynn Joins CBMJ Board of Directors and PATRIOT.TV

Written by Customer Service on January 22, 2024. Posted in Public Companies.

VENICE, FL, Jan. 22, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Conservative Broadcast Media & Journalism (CBMJ) is pleased to announce that Lieutenant General Michael Flynn (Ret.) has joined the Board of Directors of Conservative Broadcast Media & Journalism (CBMJ). General Flynn served in the U.S. Army and spent 33+ years serving in the military to protect Americans from all enemies of freedom both foreign and domestic before being named as 24th National Security Advisor under President Donald J. Trump. General Flynn comes with a wealth of experience with his background in global intelligence, international affairs and national security, which our team at PATRIOT.TV plans to leverage as we build a world class media platform for all Americans. “We know we face a battle of narratives in a saturated information age...

Newton Shafts, a Division of Sacks Parente, Announces the Signing of PGA TOUR Champions Player Ken Duke as its First Player to its Roster

Written by Customer Service on January 22, 2024. Posted in Public Companies.

CAMARILLO, CA, Jan. 22, 2024 (GLOBE NEWSWIRE) — Newton Golf Shafts, the newly established business division of Sacks Parente Golf, Inc. (Nasdaq: SPGC) (“SPG” or the “Company”) specializing in advanced shafts using proprietary carbon fiber technology, announces the signing of PGA TOUR Champions player Ken Duke as its first player to represent the Newton brand. Duke has chosen to use the new Newton Motion Shaft in his driver during the upcoming 2024 season. Following his victory at last year’s Shaw Charity Classic on the PGA TOUR Champions, Duke made the switch to the Newton Motion shaft at the TOUR’S Constellation FURYK & FRIENDS event in October. Notably, he ranked first in driving accuracy in that event, successfully hitting 40 of 42 fairways, setting the stage for a series of impressive performances. Since incorporating...

Alliance Entertainment Regains Compliance with Nasdaq Minimum Bid Price Rule

Written by Customer Service on January 22, 2024. Posted in Public Companies.

PLANTATION, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT) (“Alliance Entertainment”, “Company”), a distributor and wholesaler of the world’s largest in stock selection of music, movies, video games, electronics, arcades, toys and collectibles, announced today that on January 19, 2024, the Company received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that for the ten consecutive business days from January 4, 2024, to January 18, 2024, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, Alliance Entertainment has regained compliance with Nasdaq Listing Rule 5550(a)(2). About Alliance Entertainment Alliance Entertainment (NASDAQ: AENT) is a premier distributor of music, movies, toys, collectibles,...

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

Written by Customer Service on January 22, 2024. Posted in Public Companies.

DALLAS, Jan. 22, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS), today announced that it will present clinical data on its TSHA-102 program in evaluation for Rett syndrome during an oral poster presentation at the upcoming British Paediatric Neurology Association (BPNA) 2024 Annual Conference, taking place in Bristol, England from January 24-26, 2024. The presentation will include previously disclosed clinical data from the first two adult patients with stage four Rett syndrome dosed with TSHA-102 in the REVEAL Phase 1/2 adolescent and adult trial in Canada. The Company expects to provide further updates on available clinical data...

Ceridian to change ticker symbol to ‘DAY’ on NYSE and TSX effective February 1

Written by Customer Service on January 22, 2024. Posted in Public Companies.

TORONTO and MINNEAPOLIS, Jan. 22, 2024 (GLOBE NEWSWIRE) — Ceridian HCM Holding Inc. (NYSE: CDAY; TSX: CDAY) (the “Company”), a global leader in human capital management (HCM) technology, today announced its ticker symbol will change to DAY on the New York Stock Exchange and Toronto Stock Exchange, effective February 1, 2024. This will replace the Company’s current ticker symbol, CDAY, which has been in use since the Company’s initial public offering in 2018. The change is in connection to the Company’s brand transition to Dayforce, which was announced on October 3, 2023. No action is required to be taken by current shareholders in connection with the ticker symbol change. The Company’s common stock will continue to be listed on the NYSE and TSX and its CUSIP number will remain unchanged. About Ceridian Ceridian. Makes Work Life...

Southern States Bancshares, Inc. Announces Fourth Quarter 2023 Financial Results

Written by Customer Service on January 22, 2024. Posted in Earnings Releases And Operating Results.

Fourth Quarter 2023 Performance and Operational HighlightsCore net income(1) of $7.3 million, or $0.81 per diluted share(1) Net income of $8.9 million, or $0.99 per diluted share Net interest income of $20.4 million, a decrease of $327,000 from the prior quarter Net interest margin (“NIM”) of 3.69%, down 9 basis points from the prior quarter NIM of 3.71% on a fully-taxable equivalent basis (“NIM – FTE”)(1) Return on average assets (“ROAA”) of 1.53%; return on average stockholders’ equity (“ROAE”) of 17.02%; and return on average tangible common equity (“ROATCE”)(1) of 18.62% Core ROAA(1) of 1.26%; and core ROATCE(1) of 15.26% Efficiency ratio of 41.48%; and core efficiency ratio of 45.78% Linked-quarter loan growth was 24.7% annualized Linked-quarter total deposits grew 21.1% annualized Linked-quarter total deposits, excluding...

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

Written by Customer Service on January 22, 2024. Posted in Public Companies.

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., will join the Company as chief executive officer (CEO), effective January 27, 2024, and will also be appointed to the Company’s Board of Directors. SIGA’s current CEO, Dr. Phil Gomez, will retire from SIGA on January 26, 2024. “The appointment of Diem Nguyen as our new CEO marks a significant milestone for SIGA as we continue to expand our partnerships with governments across the world in global health security initiatives and medical countermeasure preparedness,” said Joseph (Chip) Marshall, chair of the Nominating and Corporate Governance Committee of the Company’s Board of Directors. “Diem’s scientific expertise and...

Platinex Reports the Voting Results from its AGSM and Announces New Director

Written by Customer Service on January 22, 2024. Posted in Public Companies.

TORONTO, Jan. 22, 2024 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“Platinex” or the “Company”) reports the voting results from its Annual General Special Meeting of shareholders (the “Meeting”) held on January 16, 2024. Shareholders holding 129,324,513 shares or 42.53% of the issued and outstanding shares of the Company (as at the record date January 16, 2024) were represented in person or by proxy at the Meeting and voted in favour of all matters brought before the Meeting as outlined in the Company’s Management Information Circular dated December 08, 2023. The results have been filed on SEDAR, www.sedar.com. The Company’s shareholders set the number of directors of the Company for the ensuing year at six. The six Directors included one new nominee appointee, Mr. Rajesh Sharma. Platinex...

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

Written by Customer Service on January 22, 2024. Posted in Public Companies.

HOUSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumors, announced today that the United States Adopted Names (USAN) Council, and the World Health Organization (WHO) International Nonproprietary Names (INN) expert committee has approved “neldaleucel” as the nonproprietary (generic) name for MT-601, a multi-tumor associated antigen (multiTAA)-specific T cell product candidate for the treatment of patients with lymphoma. The USAN Council in close collaboration with the WHO established INN expert committee select and assign a single unique name of worldwide acceptability for each active substance that is to be marketed as a pharmaceutical,...

Day: January 22, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals